Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Combining Pembrolizumab and Ipilimumab in NSCLC Treatment: KEYNOTE-598 Phase 3 Study Apr 20, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) IPSOS Clinical Trial: Atezolizumab in Non-Small Cell Lung Cancer Treatment Naïve Participants Apr 20, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Adjuvant Therapy with Canakinumab for Completely Resected NSCLC: CANOPY-A Phase 3 Trial Apr 20, 2023
Bladder Cancer,Genitourinary Cancer KEYNOTE-676 Study Shows Improved Efficacy and Safety for Non-Muscle Invasive Bladder Cancer Treatment Apr 20, 2023
Bladder Cancer,Genitourinary Cancer COXEN: Revolutionizing Chemotherapy Treatment for Bladder Cancer Patients Apr 20, 2023
Bladder Cancer,Genitourinary Cancer Oral Infigratinib for Invasive Urothelial Carcinoma with FGFR3 Genetic Alterations: A Promising Therapy Apr 20, 2023
Bladder Cancer,Genitourinary Cancer Targeting Molecular Alterations in Advanced Solid Tumors: My Pathway Study Phase 2A Study Apr 20, 2023
Bladder Cancer,Genitourinary Cancer Safety and Efficacy of sEphB4-HSA+Pembrolizumab in Patients with Solid Tumors: Phase 2 Trial Apr 20, 2023
